Beside modifying ECM proteins interactions, extracellular TG2 was found to activate nuclear factor-kappa B (NF-κB) signaling, leading to CD44 up-regulation and EMT activation, contributing to increased cancer cell invasiveness and peritoneal dissemination [59]. This evidence concerns the gene TGM2 and cancer.